BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20639899)

  • 1. SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML.
    Wimmer P; Schreiner S; Everett RD; Sirma H; Groitl P; Dobner T
    Oncogene; 2010 Oct; 29(40):5511-22. PubMed ID: 20639899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.
    Wimmer P; Berscheminski J; Blanchette P; Groitl P; Branton PE; Hay RT; Dobner T; Schreiner S
    Oncogene; 2016 Jan; 35(1):69-82. PubMed ID: 25772236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies.
    Pennella MA; Liu Y; Woo JL; Kim CA; Berk AJ
    J Virol; 2010 Dec; 84(23):12210-25. PubMed ID: 20861261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.
    Müncheberg S; Hay RT; Ip WH; Meyer T; Weiß C; Brenke J; Masser S; Hadian K; Dobner T; Schreiner S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adenovirus E1B-55K oncoprotein induces SUMO modification of p53.
    Muller S; Dobner T
    Cell Cycle; 2008 Mar; 7(6):754-8. PubMed ID: 18461721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells.
    Schreiner S; Wimmer P; Groitl P; Chen SY; Blanchette P; Branton PE; Dobner T
    J Virol; 2011 Sep; 85(17):8752-65. PubMed ID: 21697482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conserved E1B-55K SUMOylation in Different Human Adenovirus Species Is a Potent Regulator of Intracellular Localization.
    Kolbe V; Ip WH; Kieweg-Thompson L; Lang J; Gruhne J; Meyer T; Wilkens B; Schie M; Thünauer R; Schreiner S; Bertzbach LD; Rodríguez E; Dobner T
    J Virol; 2022 Feb; 96(3):e0083821. PubMed ID: 34787461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.
    Higginbotham JM; O'Shea CC
    J Virol; 2015 Oct; 89(20):10260-72. PubMed ID: 26223632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-Protein Interactions Facilitate E4orf6-Dependent Regulation of E1B-55K SUMOylation in HAdV-C5 Infection.
    Fiedler M; Ip WH; Hofmann-Sieber H; Wilkens B; Nkrumah FK; Zhang W; Ehrhardt A; Bertzbach LD; Dobner T
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation.
    Berscheminski J; Brun J; Speiseder T; Wimmer P; Ip WH; Terzic M; Dobner T; Schreiner S
    Oncogene; 2016 Jun; 35(24):3178-89. PubMed ID: 26477309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
    Debbas M; White E
    Genes Dev; 1993 Apr; 7(4):546-54. PubMed ID: 8384580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
    Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
    J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx.
    Zhao LY; Colosimo AL; Liu Y; Wan Y; Liao D
    J Virol; 2003 Nov; 77(21):11809-21. PubMed ID: 14557665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells.
    Maheswaran S; Englert C; Lee SB; Ezzel RM; Settleman J; Haber DA
    Oncogene; 1998 Apr; 16(16):2041-50. PubMed ID: 9572485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation.
    Kindsmüller K; Groitl P; Härtl B; Blanchette P; Hauber J; Dobner T
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6684-9. PubMed ID: 17428914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human adenovirus E1B-55K oncoprotein coordinates cell transformation through regulation of DNA-bound host transcription factors.
    von Stromberg K; Seddar L; Ip WH; Günther T; Gornott B; Weinert SC; Hüppner M; Bertzbach LD; Dobner T
    Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2310770120. PubMed ID: 37883435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.
    Schreiner S; Wimmer P; Sirma H; Everett RD; Blanchette P; Groitl P; Dobner T
    J Virol; 2010 Jul; 84(14):7029-38. PubMed ID: 20484509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription.
    Berscheminski J; Groitl P; Dobner T; Wimmer P; Schreiner S
    J Virol; 2013 Jan; 87(2):965-77. PubMed ID: 23135708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein.
    Endter C; Kzhyshkowska J; Stauber R; Dobner T
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11312-7. PubMed ID: 11553772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear matrix localization and SUMO-1 modification of adenovirus type 5 E1b 55K protein are controlled by E4 Orf6 protein.
    Lethbridge KJ; Scott GE; Leppard KN
    J Gen Virol; 2003 Feb; 84(Pt 2):259-268. PubMed ID: 12560556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.